XML 42 R27.htm IDEA: XBRL DOCUMENT
v3.23.2

Derivative Instruments (Tables) | 6 Months Ended
--- | ---
May 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Summary of Fair Values of Derivative Instruments | The fair values of the Company’s derivative instruments are disclosed in Note 7 - Fair Value Measurements and summarized in the table below:
|  | Value as of
Balance Sheet Line Item |  | May 31, 2023 |  | November 30, 2022
Derivative instruments not designated as hedging instruments: |  |  |  |
Foreign exchange forward contracts (notional value) |  | $ | 1,649,587 |  |  | $ | 1,853,188 |
Other current assets |  | 14,548 |  |  | 9,597 |
Other accrued liabilities |  | 6,123 |  |  | 16,085 |
Derivative instruments designated as cash flow hedges: |  |  |  |
Interest rate swaps (notional value) |  | $ | — |  |  | $ | 1,000,000 |
Other current assets |  | — |  |  | 17,222 |
Derivative instruments designated as net investment hedges: |  |  |  |
Foreign currency forward contracts (notional value) |  | $ | 520,000 |  |  | $ | 523,750 |
Other accrued liabilities |  | 451 |  |  | 255 |
Other long-term liabilities |  | 26,038 |  |  | 16,420 |
Effect of Derivative Instruments on AOCI and Consolidated Statements of Earnings | The following table shows the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges and net investment hedges in Other Comprehensive Income (“OCI”) and not designated as hedging instruments in the Consolidated Statements of Operations for the periods presented:
|  |  | Three Months Ended |  | Six Months Ended
| Location of Gains (Losses) in Income |  | May 31, 2023 |  | May 31, 2022 |  | May 31, 2023 |  | May 31, 2022
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |  |  |
(Losses) gains recognized from foreign exchange contracts, net⁽¹⁾ | Cost of revenue |  | $ | (7,611) |  |  | $ | 14,013 |  |  | $ | (24,512) |  |  | $ | 4,118 |
Losses recognized from foreign exchange contracts, net⁽¹⁾ | Other expense, net |  | (2,662) |  |  | (949) |  |  | (5,225) |  |  | (1,159) |
Total |  |  | $ | (10,273) |  |  | $ | 13,064 |  |  | $ | (29,737) |  |  | $ | 2,959 |
Derivative instruments designated as cash flow hedges: |  |  |  |  |  |  |  |  |
(Losses) gains recognized in OCI on interest rate swaps |  |  | $ | (217) |  |  | $ | 14,232 |  |  | $ | 937 |  |  | $ | 26,051 |
Gains (losses) on interest rate swaps reclassified from AOCI into income | Interest expense and finance charges, net |  | $ | 2,445 |  |  | $ | (9,038) |  |  | $ | 3,583 |  |  | $ | (18,998) |
Derivative instruments designated as net investment hedges: |  |  |  |  |  |  |  |  |
(Losses) recognized in OCI on foreign exchange forward contracts⁽²⁾ |  |  | $ | (6,632) |  |  | $ | — |  |  | $ | (14,657) |  |  | $ | — |
Gains recognized in income (amount excluded from effectiveness testing)⁽²⁾ | Interest expense and finance charges, net |  | $ | 2,308 |  |  | $ | — |  |  | $ | 4,586 |  |  | $ | — |
____________________________ (1) The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies. (2) The Company had no net investment hedges outstanding during the three and six months ended May 31, 2022.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration